Concourse Financial Group Securities’s Telix Pharmaceuticals TLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
9766
2024
Q4
Hold
0
9791
2024
Q3
Hold
0
9640
2024
Q2
Hold
0
9314